- Raised Undisclosed Round, Jun 2024
About
ST Innovative Diagnostics (ST Diagnostics) is an Israeli startup focused on developing a non-invasive, real-time blood test for the early detection and monitoring of various malignancies. The company's breakthrough technology is based on Fibrinogen Like Protein 2 (FGL2) activity in platelets, showing high accuracy, sensitivity, and specificity in clinical studies for Lymphoma, Lung-Cancer, Colon & Prostate Cancers, and Cutaneous T-Cell Lymphoma. The company aims to create a comprehensive FGL2 baseline profiling database using AI to develop a predictive model for routine cancer screening. Their product, LymFollow, is an innovative diagnostic kit for monitoring treatment response and relapse prediction in aggressive Non-Hodgkin's Lymphoma patients. The company holds 7 patents across the US, Europe, China, Hong Kong, and Israel.
Funding history · 1 round · — total
Q&A
- What is ST Innovative Diagnostics' primary focus?
- ST Innovative Diagnostics focuses on developing a novel blood-based test for monitoring malignancies and predicting relapse across various cancers.
- What is the core technology behind ST Innovative Diagnostics' test?
- The company's proprietary technology measures Fibrinogen Like Protein 2 (FGL2) activity in platelets, enabling non-invasive disease monitoring.
- What clinical evidence supports ST Innovative Diagnostics' technology?
- Proof-of-concept clinical studies have shown a high correlation with PET/CT imaging in Non-Hodgkin's Lymphoma, Prostate Cancer, and Cutaneous T-Cell Lymphoma.
- What are the potential future applications for ST Innovative Diagnostics' technology?
- The technology shows promise for early detection of treatment resistance in NHL patients and is planned to expand to solid tumor monitoring and diagnosis, including Metastatic Colorectal and Pancreatic Cancers.
- When was ST Innovative Diagnostics founded?
- ST Innovative Diagnostics was founded in July 2022.
- What is ST Innovative Diagnostics' current employee count?
- ST Innovative Diagnostics has 1-10 employees.
- What is the total funding raised by ST Innovative Diagnostics to date?
- As of July 2024, ST Innovative Diagnostics has raised a total of $70,000.
- Who is the Chief Science Officer at ST Innovative Diagnostics?
- Esther Rabizadeh is the Chief Science Officer at ST Innovative Diagnostics.
Team · 1
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | st-diagnostic.com |
|---|---|
| linkedin.com/company/103237856 |
Identifiers & details
| Legal name | ST Innovative Diagnostics Ltd. |
|---|---|
| Founded | 2022-7 |
| Employees (exact) | 5 |
Radar intelligence
Patents
| EPO | 1 |
|---|
Web history (Wayback)
| Domain | st-diagnostic.com |
|---|
Certificate / subdomain footprint
| Subdomains | 1 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 516655594 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2022-07-28 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | yes |
| Active charges / liens | 0 |
| Registry events | 0 |
| Registered address | סמ האנקור 12 באר יעקב |